The effect of diurnal variation, CYP2B6 genotype, and age on the pharmacokinetics of nevirapine in African Children

The effect of diurnal variation, CYP2B6 genotype, and age on the pharmacokinetics of nevirapine in African Children

<h4>Objective</h4> <p>We aimed to characterise the effects of CYP2B6 polymorphisms, diurnal variation, and demographic factors on nevirapine pharmacokinetics in African children.</p> <h4>Methods</h4> <p>Nonlinear mixed-effects modelling conducted in NONMEM...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид:	Bienczak, A, Cook, A, Wiesner, L, Mulenga, V, Kityo, C, Kekitiinwa, A, Walker, A, Owen, A, Gibb, D, Burger, D, McIlleron, H, Denti, P
Формат:	Journal article
Хэвлэсэн:	Oxford University Press 2016

Ижил төстэй зүйлс

Determinants of virological outcome and adverse events in African children treated with paediatric nevirapine fixed-dose-combination tablets
-н: Bienczak, A, зэрэг
Хэвлэсэн: (2017)

The impact of genetic polymorphisms on the pharmacokinetics of efavirenz in African children
-н: Bienczak, A, зэрэг
Хэвлэсэн: (2016)

Pharmacokinetics of nevirapine in HIV-infected children under 3 years on rifampicin-based antituberculosis treatment.
-н: Oudijk, J, зэрэг
Хэвлэсэн: (2012)

Plasma efavirenz exposure, sex, and age predict virological response in HIV-infected African children.
-н: Bienczak, A, зэрэг
Хэвлэсэн: (2016)

Determining targets for antiretroviral drug concentrations: a causal framework illustrated with pediatric efavirenz data from the CHAPAS-3 trial
-н: Schomaker, M, зэрэг
Хэвлэсэн: (2024)

Nevirapine, stavudine and lamivudine pharmacokinetics in African children on paediatric fixed-dose combination tablets.
-н: L'homme, R, зэрэг
Хэвлэсэн: (2008)

Pharmacokinetics of nevirapine in HIV-infected infants weighing 3 kg to less than 6 kg taking paediatric fixed dose combination tablets.
-н: Fillekes, Q, зэрэг
Хэвлэсэн: (2012)

Is nevirapine dose-escalation appropriate in young, African, HIV-infected children?
-н: Fillekes, Q, зэрэг
Хэвлэсэн: (2013)

Differential impact of nevirapine on artemether-lumefantrine pharmacokinetics in individuals stratified by CYP2B6 c.516G>T genotypes
-н: Abdullahi, ST, зэрэг
Хэвлэсэн: (2020)

Limited sampling models to predict the pharmacokinetics of nevirapine, stavudine, and lamivudine in HIV-infected children treated with pediatric fixed-dose combination tablets.
-н: Burger, D, зэрэг
Хэвлэсэн: (2010)

Strategies for nevirapine initiation in HIV-infected children taking pediatric fixed-dose combination "baby pills" in Zambia: a randomized controlled trial.
-н: Mulenga, V, зэрэг
Хэвлэсэн: (2010)

Nevirapine clearance from plasma in African adults stopping therapy: a pharmacokinetic substudy.
-н: Kikaire, B, зэрэг
Хэвлэсэн: (2007)

Pharmacokinetics of antiretroviral drugs in infancy
-н: Helen McIlleron, зэрэг
Хэвлэсэн: (2009-12-01)

Abacavir, zidovudine, or stavudine as paediatric tablets for African HIV-infected children (CHAPAS-3): an open-label, parallel-group, randomised controlled trial.
-н: Mulenga, V, зэрэг
Хэвлэсэн: (2016)

Effect of 7 days of phenytoin on the pharmacokinetics of and the development of resistance to single-dose nevirapine for perinatal HIV prevention: a randomized pilot trial.
-н: Fillekes, Q, зэрэг
Хэвлэсэн: (2013)

Virologic response to first-line efavirenz- or nevirapine-based antiretroviral therapy in HIV-infected African children
-н: Kekitiinwa, A, зэрэг
Хэвлэсэн: (2017)

Virologic response to first-line efavirenz- or nevirapine-based anti-retroviral therapy in HIV-infected African children
-н: Kekitiinwa, A, зэрэг
Хэвлэсэн: (2017)

Intrapartum single-dose carbamazepine reduces nevirapine levels faster and may decrease resistance after a single dose of nevirapine for perinatal HIV prevention.
-н: Muro, E, зэрэг
Хэвлэсэн: (2012)

Nevirapine concentrations in HIV-infected children treated with divided fixed-dose combination antiretroviral tablets in Malawi and Zambia.
-н: Ellis, J, зэрэг
Хэвлэсэн: (2007)

Drug resistance in human immunodeficiency virus type-1 infected Zambian children using adult fixed dose combination stavudine, lamivudine, and nevirapine.
-н: Gupta, R, зэрэг
Хэвлэсэн: (2010)

Getting drug doses right in children with tuberculosis (TB)
-н: H. McIlleron
Хэвлэсэн: (2014-04-01)

The role of CYP2B6 516G>T polymorphism on efavirenz/nevirapine toxicity. Implications on treatment outcomes
-н: Monkgomotsi J. Maseng, BSc, зэрэг
Хэвлэсэн: (2022-04-01)

Improved adherence to antiretroviral therapy observed among HIV-infected children whose caregivers had positive beliefs in medicine in Sub-Saharan Africa
-н: Abongomera, G, зэрэг
Хэвлэсэн: (2016)

The pharmacokinetics and acceptability of lopinavir/ritonavir minitab sprinkles, tablets, and syrups in african HIV-infected children.
-н: Musiime, V, зэрэг
Хэвлэсэн: (2014)

Pharmacokinetics of nevirapine in HIV-infected children with and without malnutrition receiving divided adult fixed-dose combination tablets.
-н: Pollock, L, зэрэг
Хэвлэсэн: (2009)

Nevirapine/zidovudine/lamivudine has superior immunological and virological responses not reflected in clinical outcomes in a 48-week randomized comparison with abacavir/zidovudine/lamivudine in HIV-infected Ugandan adults with low CD4 cell counts.
-н: Munderi, P, зэрэг
Хэвлэсэн: (2010)

Concomitant nevirapine impacts pharmacokinetic exposure to the antimalarial artemether-lumefantrine in African children.
-н: Liusheng Huang, зэрэг
Хэвлэсэн: (2017-01-01)

Pharmacokinetics of antiretroviral drug varies with formulation in the target population of children with HIV-1.
-н: Kasirye, P, зэрэг
Хэвлэсэн: (2012)

Viral rebound and emergence of drug resistance in the absence of viral load testing: a randomized comparison between zidovudine-lamivudine plus Nevirapine and zidovudine-lamivudine plus Abacavir.
-н: Ndembi, N, зэрэг
Хэвлэсэн: (2010)

Significant pharmacokinetic interactions between artemether/lumefantrine and efavirenz or nevirapine in HIV-infected Ugandan adults.
-н: Byakika-Kibwika, P, зэрэг
Хэвлэсэн: (2012)

Pharmacokinetics of antitubercular drugs in patients hospitalized with HIV-associated tuberculosis: a population modeling analysis [version 3; peer review: 1 approved, 2 approved with reservations]
-н: Helen McIlleron, зэрэг
Хэвлэсэн: (2024-03-01)

Pharmacokinetics of antitubercular drugs in patients hospitalized with HIV-associated tuberculosis: a population modeling analysis [version 2; peer review: 1 approved, 2 approved with reservations]
-н: Helen McIlleron, зэрэг
Хэвлэсэн: (2022-11-01)

Pharmacokinetics and acceptability of once- versus twice-daily lamivudine and abacavir in HIV type-1-infected Ugandan children in the ARROW Trial.
-н: Musiime, V, зэрэг
Хэвлэсэн: (2010)

A model-based approach for a practical dosing strategy for the short, intensive treatment regimen for paediatric tuberculous meningitis
-н: Roeland E. Wasmann, зэрэг
Хэвлэсэн: (2023-04-01)

Single-dose nevirapine exposure does not affect response to antiretroviral therapy in HIV-infected African children aged below 3 years.
-н: Musoke, P, зэрэг
Хэвлэсэн: (2015)

Incidence and determinants of nevirapine and efavirenz-related skin rashes in West Africans: nevirapine's epitaph?
-н: Fred Stephen Sarfo, зэрэг
Хэвлэсэн: (2014-01-01)

Influence of C-reactive protein on the pharmacokinetics of voriconazole in relation to the CYP2C19 genotype: a population pharmacokinetics analysis
-н: Jing Ling, зэрэг
Хэвлэсэн: (2024-08-01)

Effect of CYP3A5 genotypes on pharmacokinetic of tacrolimus in colombian liver transplant patients
-н: Erica Fernanda Lindarte, зэрэг
Хэвлэсэн: (2025-03-01)

Combined antiretroviral therapy with nevirapine of HIV-infected adults
-н: A V Kravchenko
Хэвлэсэн: (2004-11-01)

Gatifloxacin Pharmacokinetics/Pharmacodynamics-based Optimal Dosing for Pulmonary and Meningeal Multidrug-resistant Tuberculosis
-н: Deshpande, D, зэрэг
Хэвлэсэн: (2018)